Literature DB >> 16091038

Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion.

Franco Ferracci1, Florian D Schubot, David S Waugh, Gregory V Plano.   

Abstract

Secretion of Yop effector proteins by the Yersinia pestis plasmid pCD1-encoded type III secretion system (T3SS) is regulated in response to specific environmental signals. Yop secretion is activated by contact with a eukaryotic cell or by growth at 37 degrees C in the absence of calcium. The secreted YopN protein, the SycN/YscB chaperone and TyeA form a cytosolic YopN/SycN/YscB/TyeA complex that is required to prevent Yop secretion in the presence of calcium and prior to contact with a eukaryotic cell. The mechanism by which these proteins prevent secretion and the subcellular location where the block in secretion occurs are not known. To further investigate both the mechanism and location of the YopN-dependent block, we isolated and characterized several YopN mutants that constitutively block Yop secretion. All the identified amino-acid substitutions that resulted in a constitutive block in Yop secretion mapped to a central domain of YopN that is not directly involved in the interaction with the SycN/YscB chaperone or TyeA. The YopN mutants required an intact TyeA-binding domain and TyeA to block secretion, but did not require an N-terminal secretion signal, an intact chaperone-binding domain or the SycN/YscB chaperone. These results suggest that a C-terminal domain of YopN complexed with TyeA blocks Yop secretion from a cytosolic, not an extracellular, location. A hypothetical model for how the YopN/SycN/YscB/TyeA complex regulates Yop secretion is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091038     DOI: 10.1111/j.1365-2958.2005.04738.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  50 in total

Review 1.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Structural analysis of SepL, an enteropathogenic Escherichia coli type III secretion-system gatekeeper protein.

Authors:  Brianne J Burkinshaw; Sergio A Souza; Natalie C J Strynadka
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

3.  Regulation of Type III Secretion of Translocon and Effector Proteins by the EsaB/EsaL/EsaM Complex in Edwardsiella tarda.

Authors:  Lu Yi Liu; Pin Nie; Hong Bing Yu; Hai Xia Xie
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

4.  Characterization of the Yersinia enterocolitica type III secretion ATPase YscN and its regulator, YscL.

Authors:  Bill Blaylock; Kelly E Riordan; Dominique M Missiakas; Olaf Schneewind
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

5.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

6.  Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag.

Authors:  Julie Torruellas Garcia; Franco Ferracci; Michael W Jackson; Sabrina S Joseph; Isabelle Pattis; Lisa R W Plano; Wolfgang Fischer; Gregory V Plano
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells.

Authors:  Alison J Davis; Joan Mecsas
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

8.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

9.  LcrV mutants that abolish Yersinia type III injectisome function.

Authors:  Katherine Given Ligtenberg; Nathan C Miller; Anthony Mitchell; Gregory V Plano; Olaf Schneewind
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

10.  YopR impacts type III needle polymerization in Yersinia species.

Authors:  Bill Blaylock; Bryan J Berube; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2009-12-07       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.